Geetha Manjunath
Geetha Manjunath is the Founder, CEO and CTO of NIRAMAI Health
Dr. Geetha Manjunath is the Founder, CEO and CTO of NIRAMAI Health Analytix, and has led the company to develop a breakthrough AI solution for detecting early stage breast cancer in a non-invasive radiation-free manner.
Geetha holds a PhD from IISc and management education from Kellogg’s Chicago. She comes with over 25 years of experience in IT innovation.
She has proposed and led multiple AI projects at Xerox Research and Hewlett Packard India. Before starting NIRAMAI, Geetha was a Lab Director for Data Analytics Research at Xerox India.
Geetha has received many international and national recognition for her innovations and entrepreneurial work, including CSI Gold Medal, BIRAC WinER Award 2018 and is also on the
Forbes List of Top 20 Self-Made Women 2020. She was declared the winner of Women Health Innovation Showcase Asia, Accenture Vahini Innovator of the Year Award from Economic
Times and Women Entrepreneur of the Year 2020 by BioSpectrum India. Geetha is also an inventor of 20 US patents and more pending grant.
Breast cancer is the leading cause of cancer deaths in women today.
According to the World Health Organization (WHO), one in every 12 women have the risk of a breast abnormality. Early diagnosis is very critical to decrease mortality rates.
NIRAMAI, have developed a novel artificial intelligence-based medical device to detect breast cancer at a much earlier stage than traditional methods or self-examination.
Their solution is a low cost, accurate, automated, portable cancer screening tool that can be operated in any clinic.
Their imaging method is radiation free, non-touch, not painful and works for women of all ages.
The core technology of solution has been developed using patented machine learning algorithms for reliable and accurate detection of breast cancer.
This unique solution can be used as a cancer diagnosis test in hospitals, for regular preventive health checkups, and also for large scale screening in rural and semi-urban areas.
Niramai Thermalytix is available in 30 cities in India across 200+ Hospitals and Diagnostic Centers. Their customers include Apollo Clinics, HCG, Narayana Health, Rainbow Hospitals among others. Niramai test is also available in United Arab Emirates, Kenya, Sweden, Turkey, and Philippines through our distributors.Madhuri Awande
Niramai Health Analytix Geetha Manjunath
hashtag#womenfounder hashtag#startup hashtag#entrepreneur
Visit our website: https://lnkd.in/dwVWAA33